As of 2026-03-20, the Relative Valuation of Silverback Therapeutics Inc (SBTX) is (22.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.87 USD, the upside of Silverback Therapeutics Inc based on Relative Valuation is -482.6%.
The range of the Relative Valuation is (21.35) - (24.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.2x - 27.2x | 24.6x |
| Forward P/E multiples | 21.5x - 25.6x | 22.1x |
| Fair Price | (21.35) - (24.66) | (22.46) |
| Upside | -463.8% - -520.1% | -482.6% |
| Date | P/E |